Biomarker Expression Analysis via Cell Clustering Algorithm

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing and visualizing biomarker expression in cellular samples face challenges in efficiently processing and interpreting the vast biological complexity of multiplexing and image analysis data, limiting the ability to identify patterns and make meaningful diagnoses or prognoses.

Innovation Solution

A process and system that use numerical evaluation and computer algorithms to group cells with similar biomarker expression patterns by minimizing variance, creating new data points for each group and repeating the analysis until a predetermined number of groups is reached, allowing for enhanced visualization and analysis of biomarker data.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If multiplexing and image analysis are used to examine multiple biomarkers simultaneously, then the quantity of biomarkers that can be analyzed is improved, but the complexity of data analysis increases

Engineering Contradiction:
Improvenumber of biomarkers analyzedVSAvoiddata analysis complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent segments the complex data analysis process into distinct computational steps: (1) extracting signal intensity values from images, (2) normalizing data across samples, (3) applying dimensionality reduction techniques, and (4) performing clustering analysis. This segmentation makes the analysis of multiple biomarkers manageable and systematic.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces intermediate computational representations including normalized expression matrices, principal component scores, and clustering labels that mediate between the raw image data and the final biological interpretations. These intermediaries simplify the relationship between multiple biomarkers and enable easier analysis.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If sequential staining and bleaching is used to test for multiple biomarkers, then the quantity of biomarkers that can be examined is improved, but the time required for analysis increases

Engineering Contradiction:
Improvenumber of biomarkers examinedVSAvoidanalysis time
Core Design Contradiction:
Adaptability or versatilityVSLoss of time

Solution Approach 1:

The patent performs preliminary computational preparations including image registration, signal extraction, and data normalization before performing the actual clustering analysis. This preliminary action optimizes the data structure in advance, reducing the time required for subsequent analysis steps.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent implements automated continuous processing where image acquisition, signal extraction, normalization, and clustering are performed as continuous computational operations rather than discrete manual steps. This continuity maintains productivity throughout the analysis process.

Inventive Principle:
Principle #20Continuity of useful action

3Ease of operation

If numerical analysis algorithms are applied to group cells with similar biomarker patterns, then the ease of data analysis is improved, but the computational resources required increase

Engineering Contradiction:
Improveease of data analysisVSAvoidcomputational resources
Core Design Contradiction:
Ease of operationVSUse of energy by moving object

Solution Approach 1:

The patent extracts and focuses computational resources on the most critical analysis steps: signal intensity extraction from images, data normalization, and clustering. By taking out only the essential computational operations and eliminating redundant processing, the system achieves ease of analysis while minimizing computational resource consumption.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS8320655B2Process and system for analyzing the expression of biomarkers in cells
Publication Date: 2012.11.27 LEICA MICROSYSTEMS CMS GMBH
  • US8320655B2 patent drawing
  • US8320655B2 patent drawing
  • US8320655B2 patent drawing

AI summary

The invention relates generally to a process of analyzing and visualizing the expression of biomarkers in individual cells wherein the cells are examined to develop patterns of expression by using a grouping algorithm, and a system to perform and display the analysis.